Jazz Pharmaceuticals to settle U.S. probe for $57 million
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance…
by October Gallery
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance…
HOUSTON/CARACAS (Reuters) – U.S. oil firm ConocoPhillips (COP.N) has moved to take Caribbean assets of Venezuela’s state-run PDVSA to enforce a $2 billion arbitration award over a decade-oil nationalization of…
(Reuters) – Wells Fargo & Co said on Friday it will pay $480 million to resolve a securities fraud lawsuit related to a sales scandal that surfaced in 2016. FILE…
WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling controlled substances for allegedly selling unusually large quantities of opioids…
(Reuters) – Iowa Governor Kim Reynolds signed into law on Friday a bill outlawing abortion after a fetal heartbeat is detected, which often occurs at six weeks and before a…
NEW YORK (Reuters) – Two partners at the hedge fund Deerfield Management and two others were found guilty on Thursday of charges stemming from what prosecutors have described as an…
WASHINGTON (Reuters) – The U.S. Justice Department on Thursday disclosed the filing of criminal charges against former Volkswagen AG (VOWG_p.DE) Chief Executive Martin Winterkorn, accusing him of conspiring to cover…
LONDON (Reuters) – As many as 270 women’s lives may have been shortened after an IT failure in England’s breast cancer screening program meant 450,000 patients were not invited for…
(Reuters) – Johnson & Johnson on Wednesday secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded $151 million to five people who blamed injuries they suffered…
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement. FILE PHOTO: Fresenius headquarters in…